Filter
2268
Filtered Results: 2268
Text search:
receiving
medicines
Featured
Recommendations
232
New Publications
680
Language
Document type
No document type
1327
Studies & Reports
329
Guidelines
295
Manuals
124
Strategic & Response Plan
82
Training Material
34
Fact sheets
34
Situation Updates
27
Infographics
13
Resource Platforms
2
Brochures
1
Countries / Regions
India
135
Kenya
79
Global
74
South Africa
65
Ethiopia
55
Nepal
53
Uganda
50
Tanzania
44
Bangladesh
44
Western and Central Europe
43
Zambia
41
Malawi
41
Ukraine
41
Myanmar / Burma
41
Liberia
40
Sierra Leone
39
Ghana
38
Nigeria
36
Latin America and the Carribbean
33
Africa
33
Rwanda
30
Syria
29
Namibia
28
Zimbabwe
24
Eastern Europe
21
Congo, Democratic Republic of
20
Mozambique
18
Venezuela
18
South–East Asia Region
15
Philippines
14
Cambodia
14
East and Southern Africa
14
Asia
14
Botswana
12
Lesotho
12
Senegal
11
West and Central Africa
11
Russia
11
Pakistan
9
South Sudan
8
Eswatini/ Swaziland
8
Middle East and North Africa
8
Moldova
8
Burkina Faso
7
Yemen
7
Lebanon
6
Indonesia
6
Colombia
6
Western Pacific Region
6
Guinea
5
Cameroon
5
Haiti
5
Brazil
5
Eastern Europe and Central Asia
5
Vietnam
5
Afghanistan
4
North Macedonia
4
Poland
4
Albania
4
Laos
4
Georgia
4
Somalia
3
Jordan
3
Germany
3
Sudan
3
Benin
3
Central African Republic
3
Peru
3
Hungary
3
Sri Lanka
3
Tajikistan
3
Romania
3
Jamaica
3
United Kingdom
3
Saudi Arabia
2
Chad
2
Thailand
2
Gambia
2
Argentina
2
Madagascar
2
Paraguay
2
Bhutan
2
Palestine
2
Southern Africa
2
Timor Leste/ East Timor
2
Iran
2
Kyrgyzstan
2
Mauritius
2
Morocco
1
USA
1
Togo
1
Iraq
1
Turkey
1
Egypt
1
Papua New Guinea
1
Serbia
1
El Salvador
1
Bolivia
1
Libya
1
Mexico
1
Chile
1
Other region
1
Fiji
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Lithuania
1
Slovakia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
997
Clinical Guidelines
230
Public Health
119
Women & Child Health
110
Capacity Building
49
Key Resources
48
Pharmacy & Technologies
21
Annual Report MEDBOX
2
Toolboxes
HIV
275
TB
180
COVID-19
161
Mental Health
127
Pharmacy
86
AMR
73
Conflict
64
Caregiver
64
Ebola
46
Disability
42
NCDs
41
Refugee
36
NTDs
33
Rapid Response
32
Global Health Education
27
Natural Hazards
19
Health Financing Toolbox
17
Planetary Health
13
Polio
8
Cholera
4
Zika
2
Specific Hazards
2
Social Ethics
2
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Technical Report
AIDS Medicines and diagnostics service
July 2015
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and ...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
This bulletin focuses on the situation in Ukraine and several key refugee-receiving countries (Bulgaria, Czechia, Hungary, Poland, Republic of Moldova, Romania, and Slovakia), with the understanding that other countries in the European Region ...
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products...
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; an...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be incr...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibioti...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically ...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation ...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthi...
